CYP1A1 MspI polymorphism and acute myeloid leukemia risk: meta-analyses based on 5018 subjects

BACKGROUND: Evidence indicates that CYP1A1 MspI polymorphism might be a possible risk factor for several malignancies. A growing body of literature has been devoted to the association of CYP1A1 MspI polymorphism with acute myeloid leukemia (AML). However, the results remain conflicting. The aim of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuo, Wenlei, Zhang, Liang, Wang, Yan, Zhu, Bo, Chen, Zhengtang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3444413/
https://www.ncbi.nlm.nih.gov/pubmed/22846179
http://dx.doi.org/10.1186/1756-9966-31-62

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3444413/
https://www.ncbi.nlm.nih.gov/pubmed/22846179
http://dx.doi.org/10.1186/1756-9966-31-62

Ejemplares similares